Pathogenic Characteristics and Risk Factors for ESKAPE Pathogens Infection in Burn Patients

References

• Sadeghi-Bazargani H, Mohammadi R, Amiri S, et al. Individual-level predictors of inpatient childhood burn injuries: a case-control study. BMC Public Health. 2016;16(1):209. doi:10.1186/s12889-016-2799-126931103
   PubMed Web of Science ®Google Scholar
• Wen JJ, Cummins C, Radhakrishnan RS. Sildenafil recovers burn-induced cardiomyopathy. Cells. 2020;9(6):1393. doi:10.3390/cells9061393
   Web of Science ®Google Scholar
• Lee KC, Dretzke J, Grover L, Logan A, Moiemen N. A systematic review of objective burn scar measurements. Burns Trauma. 2016;4:14. doi:10.1186/s41038-016-0036-x27574684
   PubMed Web of Science ®Google Scholar
• Lachiewicz AM, Hauck CG, Weber DJ, Cairns BA, van Duin D. Bacterial infections after burn injuries: impact of multidrug resistance. Clin Infect Dis. 2017;65(12):2130–2136. doi:10.1093/cid/cix68229194526
   PubMed Web of Science ®Google Scholar
• Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19(2):403–434.16614255
   PubMed Web of Science ®Google Scholar
• Zhang P, Zou B, Liou YC, Huang C. The pathogenesis and diagnosis of sepsis post burn injury. Burns Trauma. 2021;9:tkaa047. doi:10.1093/burnst/tkaa04733654698
   PubMed Web of Science ®Google Scholar
• Glasser JS, Landrum ML, Chung KK, et al. Description of Streptococcus pneumoniae infections in burn patients. Burns. 2010;36(4):528–532. doi:10.1016/j.burns.2009.07.00619765906
   PubMed Web of Science ®Google Scholar
• Richwagen N, Lyles JT, Dale BLF, Quave CL. Antibacterial activity of Kalanchoe mortagei and K. fedtschenkoi against ESKAPE pathogens. Front Pharmacol. 2019;10:67. doi:10.3389/fphar.2019.0006730792655
   PubMed Web of Science ®Google Scholar
• De Oliveira DMP, Forde BM, Kidd TJ, et al. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020;33(3):e00181–e00219. doi:10.1128/CMR.00181-19.32404435
   PubMed Web of Science ®Google Scholar
• Peeters P, Ryan K, Karve S, et al. The impact of initial antibiotic treatment failure: real-world insights in patients with complicated, health care-associated intra-abdominal infection. Infect Drug Resist. 2019;12:329–343. doi:10.2147/IDR.S18411630774399
   PubMed Web of Science ®Google Scholar
• Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-131478103
   PubMed Web of Science ®Google Scholar
• Rossi R, Ciofalo M. An updated review on the synthesis and antibacterial activity of molecular hybrids and conjugates bearing Imidazole Moiety. Molecules. 2020;25(21):5133. doi:10.3390/molecules25215133
   Web of Science ®Google Scholar
• Li Z, Ding Z, Liu Y, et al. Phenotypic and genotypic characteristics of biofilm formation in clinical isolates of Acinetobacter baumannii. Infect Drug Resist. 2021;14:2613–2624. doi:10.2147/IDR.S31008134262306
   PubMed Web of Science ®Google Scholar
• Li Z, Ding Z, Yang J, et al. Carbapenem-resistant Klebsiella pneumoniae in southwest China: molecular characteristics and risk factors caused by KPC and NDM producers. Infect Drug Resist. 2021;14:3145–3158. doi:10.2147/IDR.S32424434413658
   PubMed Web of Science ®Google Scholar
• Ladhani HA, Yowler CJ, Claridge JA. Burn wound colonization, infection, and sepsis. Surg Infect. 2021;22(1):44–48. doi:10.1089/sur.2020.346
   PubMed Web of Science ®Google Scholar
• Erol S, Altoparlak U, Akcay MN, Celebi F, Parlak M. Changes of microbial flora and wound colonization in burned patients. Burns. 2004;30(4):357–361. doi:10.1016/j.burns.2003.12.01315145194
   PubMed Web of Science ®Google Scholar
• Chen H, Yang L, Cheng L, Hu XH, Shen YM. Distribution and drug resistance of pathogens in burn patients in China from 2006 to 2019. World J Clin Cases. 2021;9(10):2228–2237. doi:10.12998/wjcc.v9.i10.222833869598
   PubMed Web of Science ®Google Scholar
• Gong Y, Peng Y, Luo X, et al. Different infection profiles and antimicrobial resistance patterns between burn ICU and common wards. Front Cell Infect Microbiol. 2021;11:681731. doi:10.3389/fcimb.2021.68173134277469
   PubMed Web of Science ®Google Scholar
• Hashemzadeh M, Heydari R, Asareh Zadegan Dezfuli A, Saki M, Meghdadi H, Bakhtiyariniya P. Occurrence of multiple-drug resistance bacteria and their antimicrobial resistance patterns in burn infections from southwest of Iran. J Burn Care Res. 2021. doi:10.1093/jbcr/irab097
   Web of Science ®Google Scholar
• Escandon-Vargas K, Tangua AR, Medina P, et al. Healthcare-associated infections in burn patients: timeline and risk factors. Burns. 2020;46(8):1775–1786. doi:10.1016/j.burns.2020.04.03132593482
   PubMed Web of Science ®Google Scholar
• Karmakar A, Dua P, Ghosh C. Biochemical and molecular analysis of Staphylococcus aureus clinical isolates from hospitalized patients. Can J Infect Dis Med Microbiol. 2016;2016:9041636. doi:10.1155/2016/904163627366185
   PubMed Web of Science ®Google Scholar
• Karmakar A, Jana D, Dutta K, Dua P, Ghosh C. Prevalence of panton-valentine leukocidin gene among community acquired Staphylococcus aureus: a real-time PCR study. J Pathog. 2018;2018:4518541. doi:10.1155/2018/451854130245888
   PubMed Web of Science ®Google Scholar
• Jahanshahi A, Zeighami H, Haghi F. Molecular characterization of methicillin and vancomycin resistant Staphylococcus aureus strains isolated from hospitalized patients. Microb Drug Resist. 2018;24(10):1529–1536. doi:10.1089/mdr.2018.006929883257
   PubMed Web of Science ®Google Scholar
• Gong Y, Shen X, Huang G, et al. Epidemiology and resistance features of Acinetobacter baumannii isolates from the ward environment and patients in the burn ICU of a Chinese hospital. J Microbiol. 2016;54(8):551–558. doi:10.1007/s12275-016-6146-027480635
   PubMed Web of Science ®Google Scholar
• Sarhaddi N, Soleimanpour S, Farsiani H, et al. Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn centre of northeast Iran. J Glob Antimicrob Resist. 2017;8:60–66. doi:10.1016/j.jgar.2016.10.00928011349
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/S1473-3099(17)30753-329276051
   PubMed Web of Science ®Google Scholar
• Zhao Y, Hu K, Zhang J, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China. BMC Infect Dis. 2019;19(1):452. doi:10.1186/s12879-019-4073-531113374
   PubMed Web of Science ®Google Scholar
• El Bannah AMS, Nawar NN, Hassan RMM, Salem STB. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Egypt: clonal spread of blaOXA-23. Microb Drug Resist. 2018;24(3):269–277. doi:10.1089/mdr.2017.005728783427
   PubMed Web of Science ®Google Scholar
• Jain M, Sharma A, Sen MK, Rani V, Gaind R, Suri JC. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Microb Pathog. 2019;128:75–81. doi:10.1016/j.micpath.2018.12.02330562602
   PubMed Web of Science ®Google Scholar
• Manandhar S, Zellweger RM, Maharjan N, et al. A high prevalence of multi-drug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and carbapenemase-encoding genes. Ann Clin Microbiol Antimicrob. 2020;19(1):48. doi:10.1186/s12941-020-00390-y33087115
   PubMed Web of Science ®Google Scholar
• Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215(suppl_1):S28–S36. doi:10.1093/infdis/jiw28228375512
   PubMed Web of Science ®Google Scholar
• Gallaher JR, Banda W, Lachiewicz AM, Krysiak R, Cairns BA, Charles AG. Colonization with multidrug-resistant Enterobacteriaceae is associated with increased mortality following burn injury in Sub-Saharan Africa. World J Surg. 2018;42(10):3089–3096. doi:10.1007/s00268-018-4633-729696325
   PubMed Web of Science ®Google Scholar
• Mirzaei B, Babaei R, Bazgir ZN, Goli HR, Keshavarzi S, Amiri E. Prevalence of Enterobacteriaceae spp. and its multidrug-resistant rates in clinical isolates: a two-center cross-sectional study. Mol Biol Rep. 2021;48(1):665–675. doi:10.1007/s11033-020-06114-x33389531
   PubMed Web of Science ®Google Scholar
• Cohen Mendel L, Amity K, Katz DE, Lazarovitch T, Zaidenstein R, Marchaim D. The epidemiology of carbapenem resistant Enterobacter spp: a case-case-control matched analysis. Infect Control Hosp Epidemiol. 2021;42(6):754–759. doi:10.1017/ice.2020.128633228816
   PubMed Web of Science ®Google Scholar
• Liao W, De Wang L, Li D, et al. High prevalence of 16s rRNA methylase genes among carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates in a Chinese Tertiary Hospital. Microb Drug Resist. 2021;27(1):44–52. doi:10.1089/mdr.2019.048232429790
   PubMed Web of Science ®Google Scholar
• Yu X, Zhang W, Zhao Z, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates with focus on antimicrobial resistance. BMC Genomics. 2019;20(1):822. doi:10.1186/s12864-019-6225-931699025
   PubMed Web of Science ®Google Scholar
• Madaha EL, Gonsu HK, Bughe RN, Fonkoua MC, Ateba CN, Mbacham WF. Occurrence of blaTEM and blaCTXM genes and biofilm-forming ability among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii in Yaounde, Cameroon. Microorganisms. 2020;8(5):708. doi:10.3390/microorganisms8050708
   Web of Science ®Google Scholar
• Francisco J, Aragao I, Cardoso T. Risk factors for long-term mortality in patients admitted with severe infection. BMC Infect Dis. 2018;18(1):161. doi:10.1186/s12879-018-3054-429621990
   PubMed Web of Science ®Google Scholar
• Pragasam AK, Vijayakumar S, Bakthavatchalam YD, et al. Molecular characterisation of antimicrobial resistance in Pseudomonas aeruginosa and Acinetobacter baumannii during 2014 and 2015 collected across India. Indian J Med Microbiol. 2016;34(4):433–441. doi:10.4103/0255-0857.19537627934820
   PubMed Web of Science ®Google Scholar
• Dylewksi ML, Baker M, Prelack K, et al. The safety and efficacy of parenteral nutrition among pediatric patients with burn injuries. Pediatr Crit Care Med. 2013;14(3):e120–e125. doi:10.1097/PCC.0b013e3182712b2b23392358
   PubMed Web of Science ®Google Scholar
• You T, Zhang H, Guo L, Ling KR, Hu XY, Li LQ. Differences in clinical characteristics of early- and late-onset neonatal sepsis caused by Klebsiella pneumoniae. Int J Immunopathol Pharmacol. 2020;34:2058738420950586. doi:10.1177/205873842095058632816593
   PubMed Web of Science ®Google Scholar
• Hiengrach P, Panpetch W, Worasilchai N, et al. Administration of candida albicans to dextran sulfate solution treated mice causes intestinal dysbiosis, Emergence and dissemination of intestinal Pseudomonas Aeruginosa and lethal sepsis. Shock. 2020;53(2):189–198. doi:10.1097/SHK.000000000000133930829903
   PubMed Web of Science ®Google Scholar